Kasvu Raises €30 Million for TrkB Program
Finland-based Kasvu Therapeutics raised a €30 million Series A led by Hadean Ventures, with Tesi, Innovestor and other Finnish science investors participating. Proceeds are intended to take KTX-0141, a small-molecule positive allosteric modulator of…
